Hepalink Pharma's US unit plans to invest in Quest PharmaTech, OncoQuest
Monday, October 12, 2015
Shenzhen Hepalink Pharmaceutical Co Ltd Says its U.S. unit, Hepalink USA Inc, plans to invest C$2 million in Quest PharmaTech Inc by subscribing 25 million new shares.
Says its U.S. unit, Hepalink USA Inc, plans to invest $13 million in OncoQuest Inc by subscribing preference shares.
Says plans to invest $5 million to set up JV in China with OncoQuest Inc.
reuters.com
